Clinical Trial Update: Allogeneic, Antigen-Presenting, GM-CSF-secreting, SV-BR-1-GM Whole Cell-Therapeutic Vaccine and Immunotherapy: A Phase I Pilot Safety and Feasibility Study for Solid Tumor Patients With CNS Metastases [Phase 1]

View source ↗

Summary

A Phase I pilot safety and feasibility study of the SV-BR-1-GM whole-cell vaccine for solid tumors with CNS metastases (brain metastases and leptomeningeal meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Leptomeningeal Metastasis

Drugs mentioned

• SV-BR-1-GM

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Brain Metastases, Leptomeningeal Metastasis | Phase 1 | Status: NOT_YET_RECRUITING